Literature DB >> 12809367

Chaste tree (Vitex agnus-castus)--pharmacology and clinical indications.

W Wuttke1, H Jarry, V Christoffel, B Spengler, D Seidlová-Wuttke.   

Abstract

Extracts of the fruits of chaste tree (Vitex agnus castus = AC) are widely used to treat premenstrual symptoms. Double-blind placebo-controlled studies indicate that one of the most common premenstrual symptoms, i.e. premenstrual mastodynia (mastalgia) is beneficially influenced by an AC extract. In addition, numerous less rigidly controlled studies indicate that AC extracts have also beneficial effects on other psychic and somatic symptoms of the PMS. Premenstrual mastodynia is most likely due to a latent hyperprolactinemia, i.e. patients release more than physiologic amounts of prolactin in response to stressful situations and during deep sleep phases which appear to stimulate the mammary gland. Premenstrually this unphysiological prolactin release is so high that the serum prolactin levels often approach heights which are misinterpreted as prolactinomas. Since AC extracts were shown to have beneficial effects on premenstrual mastodynia serum prolactin levels in such patients were also studied in one double-blind, placebo-controlled clinical study. Serum prolactin levels were indeed reduced in the patients treated with the extract. The search for the prolactin-suppressive principle(s) yielded a number of compounds with dopaminergic properties: they bound to recombinant DA2-receptor protein and suppressed prolactin release from cultivated lactotrophs as well as in animal experiments. The search for the chemical identity of the dopaminergic compounds resulted in isolation of a number of diterpenes of which some clerodadienols were most important for the prolactin-suppressive effects. They were almost identical in their prolactin-suppressive properties than dopamine itself. Hence, it is concluded that dopaminergic compounds present in Vitex agnus castus are clinically the important compounds which improve premenstrual mastodynia and possibly also other symptoms of the premenstrual syndrome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12809367     DOI: 10.1078/094471103322004866

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  24 in total

1.  Too much effectiveness from a herbal drug.

Authors:  Alfredo Vannacci; Francesco Lapi; Roberto Baronti; Eugenia Gallo; Luigi Gori; Alessandro Mugelli; Fabio Firenzuoli
Journal:  Br J Clin Pharmacol       Date:  2009-04       Impact factor: 4.335

2.  Comparison of fructus agni casti and flurbiprofen in the treatment of cyclic mastalgia in premenopausal women.

Authors:  Tolga Dinç; Faruk Coşkun
Journal:  Ulus Cerrahi Derg       Date:  2014-03-01

3.  Casticin, a flavonoid isolated from Vitex rotundifolia, inhibits prolactin release in vivo and in vitro.

Authors:  Qi YE; Qiao-yan ZHANG; Cheng-jian ZHENG; Yang WANG; Lu-ping QIN
Journal:  Acta Pharmacol Sin       Date:  2010-11-01       Impact factor: 6.150

Review 4.  Vitex negundo and its medicinal value.

Authors:  Balraj Singh Gill; Richa Mehra; Sanjeev Kumar
Journal:  Mol Biol Rep       Date:  2018-10-11       Impact factor: 2.316

Review 5.  Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings.

Authors:  Susan Arentz; Jason Anthony Abbott; Caroline Anne Smith; Alan Bensoussan
Journal:  BMC Complement Altern Med       Date:  2014-12-18       Impact factor: 3.659

6.  Phytoconstituents from Vitex agnus-castus fruits.

Authors:  Shao-Nong Chen; J Brent Friesen; Donna Webster; Dejan Nikolic; Richard B van Breemen; Z Jim Wang; Harry H S Fong; Norman R Farnsworth; Guido F Pauli
Journal:  Fitoterapia       Date:  2010-12-13       Impact factor: 2.882

Review 7.  A comprehensive review of clinical studies with herbal medicine on polycystic ovary syndrome (PCOS).

Authors:  Arezoo Moini Jazani; Hamidreza Nasimi Doost Azgomi; Alireza Nasimi Doost Azgomi; Ramin Nasimi Doost Azgomi
Journal:  Daru       Date:  2019-11-18       Impact factor: 3.117

Review 8.  Botanicals and Their Bioactive Phytochemicals for Women's Health.

Authors:  Birgit M Dietz; Atieh Hajirahimkhan; Tareisha L Dunlap; Judy L Bolton
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

9.  High-content screening and mechanism-based evaluation of estrogenic botanical extracts.

Authors:  Cassia R Overk; Ping Yao; Shaonong Chen; Shixing Deng; Ayano Imai; Matthew Main; Andreas Schinkovitz; Norman R Farnsworth; Guido F Pauli; Judy L Bolton
Journal:  Comb Chem High Throughput Screen       Date:  2008-05       Impact factor: 1.339

Review 10.  Update on research and treatment of premenstrual dysphoric disorder.

Authors:  Joanne Cunningham; Kimberly Ann Yonkers; Shaughn O'Brien; Elias Eriksson
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.